​Aalto Bio Reagents

​

​

​

• Founded in 1978

​

• Market leader in the development of proteins and monoclonal antibodies for the new emerging viruses, eg. Dengue, Chikungunya and Zika

​

• Custom manufacture of new recombinant antigens

​

• Routine manufacture of bulk antigens and antibodies

​

• Full raw material menu for chemiluminescence platforms

​

• Europes largest provider of bulk disease state plasma for controls

​

Aalto's Latest News